Induction of nerve growth factor expression and release by mechanical and inflammatory stimuli in chondrocytes: possible involvement in osteoarthritis pain
暂无分享,去创建一个
Francis Berenbaum | Xavier Houard | F. Berenbaum | Marjolaine Gosset | Emilie Pecchi | X. Houard | Audrey Pigenet | Sabrina Priam | Laure Sudre | Marie-Charlotte Laiguillon | É. Pecchi | M. Gosset | A. Pigenet | L. Sudre | S. Priam | Marie-Charlotte Laiguillon
[1] L. Manni,et al. Role of IL-1b and TNF-a in the regulation of NGF in experimentally induced arthritis in mice , 1998, Rheumatology International.
[2] Zhihong Wu,et al. Increased synovial fluid visfatin is positively linked to cartilage degradation biomarkers in osteoarthritis , 2012, Rheumatology International.
[3] L. Rodríguez-Mañas,et al. Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity , 2009, Diabetologia.
[4] S. Ohtori,et al. Role of low-affinity nerve growth factor receptor inhibitory antibody in reducing pain behavior and calcitonin gene-related Peptide expression in a rat model of wrist joint inflammatory pain. , 2010, The Journal of hand surgery.
[5] E. Schwarz,et al. Differential regulation of EP receptor isoforms during chondrogenesis and chondrocyte maturation. , 2005, Biochemical and biophysical research communications.
[6] R. Moskowitz,et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. , 1986, Arthritis and rheumatism.
[7] W. Steers,et al. Stretch‐activated signaling of nerve growth factor secretion in bladder and vascular smooth muscle cells from hypertensive and hyperactive rats , 2000, Journal of cellular physiology.
[8] R. Levi‐montalcini,et al. Nerve growth factor and distribution of mast cells in the synovium of adult rats. , 1992, Clinical and experimental rheumatology.
[9] S. Fiorito,et al. Nerve growth factor release by human synovial fibroblasts prior to and following exposure to tumor necrosis factor-alpha, interleukin-1 beta and cholecystokinin-8: the possible role of NGF in the inflammatory response. , 2003, Clinical and experimental rheumatology.
[10] U. Schotten,et al. Regulation of nerve growth factor in the heart: the role of the calcineurin-NFAT pathway. , 2009, Journal of molecular and cellular cardiology.
[11] A. Freemont,et al. Expression and regulation of neurotrophins in the nondegenerate and degenerate human intervertebral disc , 2008, Arthritis research & therapy.
[12] O. Leo,et al. Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase/Visfatin Enzymatic Activity Identifies a New Inflammatory Pathway Linked to NAD , 2008, PloS one.
[13] M. Kvarnström,et al. Interleukin-1beta in synovial fluid from the arthritic temporomandibular joint and its relation to pain, mobility, and anterior open bite. , 1998, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[14] F. Berenbaum,et al. Synergistic Effect of Interleukin-1β and Tumor Necrosis Factor α on PGE2Production by Articular Chondrocytes Does Not Involve PLA2Stimulation , 1996 .
[15] F. Berenbaum,et al. Synergistic effect of interleukin-1 beta and tumor necrosis factor alpha on PGE2 production by articular chondrocytes does not involve PLA2 stimulation. , 1996, Experimental Cell Research.
[16] B. Fredholm,et al. Mechanisms of nerve growth factor mRNA regulation by interleukin‐1β in hippocampal cultures: Role of second messengers , 1992, Journal of neuroscience research.
[17] E. Vignon,et al. When Is Osteonecrosis Not Osteonecrosis?: Adjudication of Reported Serious Adverse Joint Events in the Tanezumab Clinical Development Program , 2016, Arthritis & rheumatology.
[18] I. Davignon,et al. Tanezumab reduces osteoarthritic knee pain: results of a randomized, double-blind, placebo-controlled phase III trial. , 2012, The journal of pain : official journal of the American Pain Society.
[19] J. Gómez-Reino,et al. What's new in our understanding of the role of adipokines in rheumatic diseases? , 2011, Nature Reviews Rheumatology.
[20] M. Matsuda,et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. , 2005, Science.
[21] T. Schnitzer,et al. Tanezumab for the treatment of pain from osteoarthritis of the knee. , 2010, The New England journal of medicine.
[22] M. Feldmann,et al. Treatmentof murine osteoarthritis withTrkAd5 reveals a pivotal rolefor nerve growth factor in non-inflammatory joint pain , 2010, PAIN®.
[23] S. B. Pedersen,et al. Differential expression of prostaglandin receptor mRNAs during adipose cell differentiation. , 1999, Prostaglandins & other lipid mediators.
[24] F. Berenbaum,et al. Proinflammatory Actions of Visfatin/Nicotinamide Phosphoribosyltransferase (Nampt) Involve Regulation of Insulin Signaling Pathway and Nampt Enzymatic Activity* , 2012, The Journal of Biological Chemistry.
[25] M. Bulló,et al. Stimulation of NGF expression and secretion in 3T3-L1 adipocytes by prostaglandins PGD2, PGJ2, and Delta12-PGJ2. , 2005, American journal of physiology. Endocrinology and metabolism.
[26] R. Levi‐montalcini,et al. Nerve growth factor in the synovial fluid of patients with chronic arthritis. , 1992, Arthritis and rheumatism.
[27] R. Seerattan,et al. Nerve growth factor improves ligament healing , 2008, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[28] O. Grimsholm,et al. Expression Patterns of Neurotrophins and Neurotrophin Receptors in Articular Chondrocytes and Inflammatory Infiltrates in Knee Joint Arthritis , 2008, Cells Tissues Organs.
[29] R. Terkeltaub,et al. The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study , 2009, Annals of the rheumatic diseases.
[30] M. Seidel,et al. Nerve growth factor in rheumatic diseases. , 2010, Seminars in arthritis and rheumatism.
[31] L. Manni,et al. Role of IL-1 beta and TNF-alpha in the regulation of NGF in experimentally induced arthritis in mice. , 1998, Rheumatology international.
[32] C. Patry,et al. Characterization of the PGE2 receptor subtype in bovine chondrocytes in culture , 1996, British journal of pharmacology.
[33] F. Sohrabji,et al. The neurotrophin receptor p75NTR mediates early anti-inflammatory effects of estrogen in the forebrain of young adult rats , 2005, BMC Neuroscience.
[34] Simon A. Jones,et al. Suppression of leukocyte infiltration and cartilage degradation by selective inhibition of pre-B cell colony-enhancing factor/visfatin/nicotinamide phosphoribosyltransferase: Apo866-mediated therapy in human fibroblasts and murine collagen-induced arthritis. , 2011, Arthritis and rheumatism.
[35] F. Berenbaum,et al. Prostaglandin E2 synthesis in cartilage explants under compression: mPGES-1 is a mechanosensitive gene , 2006, Arthritis research & therapy.
[36] M. Hochberg,et al. New treatments for osteoarthritis , 2013, Current opinion in rheumatology.
[37] F. Berenbaum,et al. Mechanical stress and prostaglandin E2 synthesis in cartilage. , 2008, Biorheology.
[38] J. E. Lee,et al. The role of nerve growth factor in hyperosmolar stress induced apoptosis , 2008, Journal of cellular physiology.
[39] Janine Wehrhahn,et al. Review: NAD + : A modulator of immune functions , 2011, Innate immunity.
[40] F. Greco,et al. Expression of NGF, Trka and p75 in human cartilage. , 2009, European journal of histochemistry : EJH.
[41] L. Ma,et al. Nerve growth factor induced after temporomandibular joint inflammation decelerates chondrocyte differentiation. , 2013, Oral diseases.
[42] Li-Dong Wu,et al. Increased serum concentrations of visfatin and its production by different joint tissues in patients with osteoarthritis , 2010, Clinical chemistry and laboratory medicine.
[43] Kaori Matsumoto,et al. Prostaglandins are powerful inducers of NGF and BDNF production in mouse astrocyte cultures , 2004, FEBS letters.
[44] J. Krueger,et al. Cytokine mRNA induction by interleukin-1β or tumor necrosis factor α in vitro and in vivo , 2008, Brain Research.
[45] U. Scapagnini,et al. Nerve growth factor inhibits some acute experimental inflammations. , 1989, Archives internationales de pharmacodynamie et de therapie.
[46] I. Davignon,et al. Tanezumab reduces osteoarthritic hip pain: results of a randomized, double-blind, placebo-controlled phase III trial. , 2013, Arthritis and rheumatism.
[47] P. Hawkins,et al. Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal study , 2011, Arthritis research & therapy.
[48] Max Hasmann,et al. FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. , 2003, Cancer research.
[49] A. Leonardi,et al. The adipokine visfatin induces tissue factor expression in human coronary artery endothelial cells: another piece in the adipokines puzzle. , 2012, Thrombosis research.
[50] F. Berenbaum,et al. Crucial role of visfatin/pre-B cell colony-enhancing factor in matrix degradation and prostaglandin E2 synthesis in chondrocytes: possible influence on osteoarthritis. , 2008, Arthritis and rheumatism.
[51] F. Berenbaum,et al. Osteoarthritis, inflammation and obesity , 2013, Current opinion in rheumatology.
[52] P. Schauerte,et al. Mechanical stretch induces nerve sprouting in rat sympathetic neurocytes , 2010, Autonomic Neuroscience.
[53] F. Berenbaum,et al. Immature murine articular chondrocytes in primary culture: a new tool for investigating cartilage. , 2005, Osteoarthritis and cartilage.
[54] Stefan Fischer,et al. Compartmentation of NAD+‐dependent signalling , 2011, FEBS letters.
[55] Haeyoun Kang,et al. Interleukin‐1β induces angiogenesis and innervation in human intervertebral disc degeneration , 2011, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[56] Jonathan Samuels,et al. Increased interleukin-1β gene expression in peripheral blood leukocytes is associated with increased pain and predicts risk for progression of symptomatic knee osteoarthritis. , 2011, Arthritis and rheumatism.
[57] M. Kvarnström,et al. Interleukin-1β in synovial fluid from the arthritic temporomandibular joint and its relation to pain, mobility, and anterior open bite , 1998 .
[58] L. Olson,et al. Regulation of β‐nerve growth factor expression by inflammatory mediators in hippocampal cultures , 1990, Journal of neuroscience research.
[59] Adam Sapirstein,et al. Interleukin-1β-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity , 2001, Nature.
[60] Yu-qi Fan,et al. Visfatin/PBEF/Nampt induces EMMPRIN and MMP-9 production in macrophages via the NAMPT-MAPK (p38, ERK1/2)-NF-κB signaling pathway. , 2011, International journal of molecular medicine.
[61] C. Fan,et al. Effects and relationship of ERK1 and ERK2 in interleukin-1β-induced alterations in MMP3, MMP13, type II collagen and aggrecan expression in human chondrocytes. , 2011, International journal of molecular medicine.
[62] H. An,et al. Proinflammatory Cytokines Stimulate the Expression of Nerve Growth Factor by Human Intervertebral Disc Cells , 2007, Spine.
[63] S. Jabbur,et al. Inflammatory mediators released following application of irritants on the rat injured incisors. The effect of treatment with anti-inflammatory drugs. , 2009, Cytokine.
[64] E. Costa,et al. Beta adrenergic and prostaglandin receptor activation increases nerve growth factor mRNA content in C6-2B rat astrocytoma cells. , 1988, The Journal of pharmacology and experimental therapeutics.
[65] G. Bianco,et al. Increased expression of nerve growth factor (NGF) and high affinity NGF receptor (p140 TrkA) in human osteoarthritic chondrocytes. , 2002, Rheumatology.
[66] H. Yamazaki,et al. Interleukin-1-induced subacromial synovitis and shoulder pain in rotator cuff diseases. , 2001, Rheumatology.